These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22576078)

  • 1. Human Herpesvirus-6 cytopathic inclusions: an exceptional and recognizable finding on skin biopsy during HHV6 reactivation after autologous stem-cell transplantation.
    Roux J; Battistella M; Fornecker L; Legoff J; Deau B; Houhou N; Bouaziz JD; Thieblemont C; Janin A
    Am J Dermatopathol; 2012 Aug; 34(6):e73-6. PubMed ID: 22576078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study.
    Dulery R; Salleron J; Dewilde A; Rossignol J; Boyle EM; Gay J; de Berranger E; Coiteux V; Jouet JP; Duhamel A; Yakoub-Agha I
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):1080-9. PubMed ID: 22212513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
    de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic microangiopathy (TMA) and stroke due to human herpesvirus-6 (HHV-6) reactivation in an adult receiving high-dose melphalan with autologous peripheral stem cell transplantation.
    Belford A; Myles O; Magill A; Wang J; Myhand RC; Waselenko JK
    Am J Hematol; 2004 Jun; 76(2):156-62. PubMed ID: 15164383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet.
    Lagadinou ED; Marangos M; Liga M; Panos G; Tzouvara E; Dimitroulia E; Tiniakou M; Tsakris A; Zoumbos N; Spyridonidis A
    Transpl Infect Dis; 2010 Oct; 12(5):437-40. PubMed ID: 20561301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.
    Wang LR; Dong LJ; Zhang MJ; Lu DP
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1031-7. PubMed ID: 17067909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis.
    Ogata M; Satou T; Inoue Y; Takano K; Ikebe T; Ando T; Ikewaki J; Kohno K; Nishida A; Saburi M; Miyazaki Y; Ohtsuka E; Saburi Y; Fukuda T; Kadota J
    Bone Marrow Transplant; 2013 Feb; 48(2):257-64. PubMed ID: 22750998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation.
    Tokimasa S; Hara J; Osugi Y; Ohta H; Matsuda Y; Fujisaki H; Sawada A; Kim JY; Sashihara J; Amou K; Miyagawa H; Tanaka-Taya K; Yamanishi K; Okada S
    Bone Marrow Transplant; 2002 Apr; 29(7):595-8. PubMed ID: 11979309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing human herpes virus 6 following hematopoietic stem cell transplantation.
    Perissinotti AJ; Gulbis A; Shpall EJ; Howell J
    J Oncol Pharm Pract; 2015 Apr; 21(2):85-92. PubMed ID: 24407957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical exanthems associated with HHV-6 reactivation after hematopoietic cell transplantation.
    Drago F; Ciccarese G; Broccolo F; Cozzani E; Parodi A
    J Clin Virol; 2015 Nov; 72():119-21. PubMed ID: 26489402
    [No Abstract]   [Full Text] [Related]  

  • 11. Fatal HHV6 infection in an immunocompromised patient presenting with skin involvement.
    Galan A; McNiff JM; Choi JN; Lazova R
    J Cutan Pathol; 2010 Feb; 37(2):277-81. PubMed ID: 19522847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human herpesvirus-6 and -7 in pediatric stem cell transplantation.
    Savolainen H; Lautenschlager I; Piiparinen H; Saarinen-Pihkala U; Hovi L; Vettenranta K
    Pediatr Blood Cancer; 2005 Nov; 45(6):820-5. PubMed ID: 15700258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation.
    Zerr DM
    J Clin Virol; 2006 Dec; 37 Suppl 1():S52-6. PubMed ID: 17276370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human herpes virus 6 reactivation following autologous hematopoietic cell transplantation - a single-center experience.
    Shargian-Alon L; Yahav D; Rozovski U; Dovrat S; Amitai I; Sela-Navon M; Pasvolsky O; Raanani P; Yeshurun M
    Leuk Lymphoma; 2019 Sep; 60(9):2230-2236. PubMed ID: 30773083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT.
    de Pagter PJ; Schuurman R; Keukens L; Schutten M; Cornelissen JJ; van Baarle D; Fries E; Sanders EA; Minnema MC; van der Holt BR; Meijer E; Boelens JJ
    Bone Marrow Transplant; 2013 Nov; 48(11):1460-4. PubMed ID: 23771003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First analysis of human herpesvirus 6T-cell responses: specific boosting after HHV6 reactivation in stem cell transplantation recipients.
    de Pagter AP; Boelens JJ; Scherrenburg J; Vroom-de Blank T; Tesselaar K; Nanlohy N; Sanders EA; Schuurman R; van Baarle D
    Clin Immunol; 2012 Sep; 144(3):179-89. PubMed ID: 22820131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of human herpesvirus-6 after haematopoietic stem cell transplantation.
    Hentrich M; Oruzio D; Jäger G; Schlemmer M; Schleuning M; Schiel X; Hiddemann W; Kolb HJ
    Br J Haematol; 2005 Jan; 128(1):66-72. PubMed ID: 15606551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome.
    Greco R; Crucitti L; Noviello M; Racca S; Mannina D; Forcina A; Lorentino F; Valtolina V; Rolla S; Dvir R; Morelli M; Giglio F; Barbanti MC; Lupo Stanghellini MT; Oltolini C; Vago L; Scarpellini P; Assanelli A; Carrabba MG; Marktel S; Bernardi M; Corti C; Clementi M; Peccatori J; Bonini C; Ciceri F
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2250-2255. PubMed ID: 27697585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome.
    Tohyama M; Hashimoto K; Yasukawa M; Kimura H; Horikawa T; Nakajima K; Urano Y; Matsumoto K; Iijima M; Shear NH
    Br J Dermatol; 2007 Nov; 157(5):934-40. PubMed ID: 17854362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human herpesvirus-6 as an inducer of porphyria cutanea tarda: implications from a case.
    Weber T; Theurich S; Christopeit M; Klapperstueck T; Behre G
    Transpl Infect Dis; 2010 Oct; 12(5):432-6. PubMed ID: 20487413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.